Provenance du réseau au premier degré de Mogens Gisselbaeck
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company.
2
| Private Company | Pharmaceuticals: Major | 2 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mogens Gisselbaeck via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
HemoCue AB
 HemoCue AB Medical SpecialtiesHealth Technology HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing. Its solutions include hematology, diabetes, data management and connectivity solutions, and accessories and consumables. The company was founded in 1982 and is heaquartered in Angelholm, Sweden. | Medical Specialties | President | |
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member | |
| University of Aarhus | College/University | Doctorate Degree | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | General Counsel | |
| University of Lund | College/University | Graduate Degree | |
| University of Surrey | College/University | Graduate Degree | |
| Karlstad University | College/University | Graduate Degree | |
| ConvaTec (Sweden) AB | Director/Board Member | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| OSSDSIGN AB | Medical Specialties | Director of Finance/CFO | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director of Finance/CFO | |
| Edinburgh Business School | College/University | Masters Business Admin | |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member | |
| PILA PHARMA AB | Biotechnology | Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Selma Diagnostics ApS | Founder | ||
| Takeda AB | Director/Board Member | ||
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Swedish Orphan Biovitrum (Belgium) SARL
 Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Suède | 13 |
| Etats-Unis | 4 |
| Royaume-Uni | 3 |
| Finlande | 2 |
| Danemark | 2 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 6 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 9 |
| General Counsel | 4 |
| Graduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Mogens Gisselbaeck
- Connexions Sociétés
